Forty Seven Inc (FTSV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FTSV | GRFS | INDV | ||
| Company | Forty Seven Inc | Grifols S.A. ADR | Indivior Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 95.46 | 7.60 | 33.64 | ||
| High | 95.52 | 7.60 | 35.50 | ||
| Low | 95.46 | 7.43 | 33.35 | ||
| Latest | 95.51 | 7.47 | 35.43 | ||
| Change | +0.05 | -0.16 | +1.72 | ||
| % Change | +0.05% | -2.10% | +5.10% | ||
| Volume | 693,900 | 474,424 | 1,521,098 | ||
| 20-Day Average Volume | 1,555,145 | 647,959 | 1,965,797 | ||
| Previous Close | 95.46 | 7.63 | 33.71 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 93.81 | 7.89 | 37.35 | ||
| 20-Day Raw Stochastic | 99.93% | 1.44% | 29.69% | ||
| 20-Day Relative Strength | 80.98 | 38.96 | 47.30 | ||
| Weighted Alpha | +174.00 | -21.99 | +111.06 | ||
| Today's Opinion | 100% Buy | 100% Sell | 72% Buy | ||
| Previous Opinion | 100% Buy | 100% Sell | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.15% since 03/30/20 | -7.58% since 05/27/26 | -5.79% since 05/27/26 | ||
| Low | 95.25 on 04/01/20 | 7.43 on 06/03/26 | 32.41 on 06/02/26 | ||
| High | 95.51 on 04/06/20 | 8.07 on 05/29/26 | 37.15 on 05/28/26 | ||
| 1-Month | |||||
| %Chg | +1.23% since 03/06/20 | -9.60% since 05/01/26 | -7.17% since 05/01/26 | ||
| Low | 88.00 on 03/18/20 | 7.43 on 06/03/26 | 32.41 on 06/02/26 | ||
| High | 95.51 on 04/06/20 | 8.47 on 05/07/26 | 41.00 on 05/07/26 | ||
| 3-Month | |||||
| %Chg | +150.62% since 01/06/20 | -13.89% since 03/03/26 | +13.25% since 03/03/26 | ||
| Low | 32.29 on 01/13/20 | 7.39 on 03/25/26 | 27.68 on 03/24/26 | ||
| High | 95.51 on 04/06/20 | 8.94 on 03/05/26 | 41.00 on 05/07/26 | ||
| 6-Month | |||||
| %Chg | +1,481.29% since 10/04/19 | -15.26% since 12/03/25 | +2.76% since 12/03/25 | ||
| Low | 5.53 on 10/23/19 | 7.39 on 03/25/26 | 27.68 on 03/24/26 | ||
| High | 95.51 on 04/06/20 | 9.77 on 02/18/26 | 41.00 on 05/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,599,379 | 5,192,788 | 4,109,990 | ||
| Shares Outstanding, K | 48,156 | 680,575 | 121,922 | ||
| Annual Sales | 15,680,000 | 8,512,650,000 | 1,239,000,000 | ||
| Annual Net Income | -87,620,000 | 454,820,000 | 210,000,000 | ||
| Last Quarter Sales | 0 | 1,989,680,000 | 317,000,000 | ||
| Last Quarter Net Income | -26,240,000 | 85,440,000 | 89,000,000 | ||
| 60-Month Beta | 0.40 | 0.65 | 0.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.19 on 07/28/25 | 0.96 on 04/30/26 | ||
| Earnings Date | 05/11/20 | 02/25/26 | 07/30/26 | ||
| Most Recent Dividend | N/A | 0.142 on 08/12/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 08/12/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 11.59 | ||